NJ BIOPHARMA CONSULTING LIMITED
No Analysis Available
Get instant AI-powered insights about this company's financial health, risks, and trends.
Order Analysis - £10- Legal registered address
- 66 Kenilworth Road Sale Greater Manchester United Kingdom M33 5DB Copied!
Latest financial results as of 11 September 2025- Current assets
- £261.09k
- Fixed assets
- £23.36k
- Current creditors
- £70.36k
- Shareholders funds
- £214.09k
View full financial accounts- Current assets
- £261.09k
- Fixed assets
- £23.36k
- Current creditors
- £70.36k
- Shareholders funds
- £214.09k
- Company number
- 10409217 Copied!
Accounts
Latest annual accounts were to 31 October 2024
Next annual accounts are due by 31 July 2026
Company financial year end is on 31 October 2025
Confirmation statement
Latest confirmation statement statement dated 18 October 2024
Next statement due by 1 November 2025
Nature of business (SIC)
74909 - Other professional, scientific and technical activities not elsewhere classified
Latest company documents
| Date | Description |
|---|---|
| 17/01/2517 January 2025 | Micro company accounts made up to 2024-10-31 |
| 24/12/2424 December 2024 | Notification of Neil Ian Johnson as a person with significant control on 2024-12-20 |
| 23/12/2423 December 2024 | Withdrawal of a person with significant control statement on 2024-12-23 |
| 23/12/2423 December 2024 | Statement of capital following an allotment of shares on 2024-12-20 |
| 31/10/2431 October 2024 | Annual accounts for year ending 31 Oct 2024 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company